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INTRODUCTION 
The STEP UP consortium and the High Impact Practices (HIP) initiative, together with other 
partners, are supporting three consultation meetings to inform use of appropriate standards of 
evidence for recommending best practices in reproductive health (RH). The first consultation 
(held on 18–19 June 2013 in New York, USA) focused on the generation and synthesis of 
evidence that can inform the production of HIP briefing documents. These documents describe 
service delivery and enabling environment practices that, if fully implemented, will maximise 
investments in a comprehensive family planning (FP) strategy. The report is available here. 
The second consultation (held on 18-19 September 2013 in Croydon, UK) built on issues 
discussed during the first consultation by focussing on the generation and synthesis of evidence 
for practice recommendations. This meeting brought together researchers and research funders 
to review the research designs and methodologies that can be used to generate evidence on the 
impact of FP/RH interventions and on their implementation, the mechanisms and structures 
through which such evidence is reviewed and translated into recommendations, and the 
implications for organizing and funding evidence generation to maximise its quality and utility. 
The third consultation, which will be held during the second quarter of 2014 in Nairobi, Kenya, will 
focus on communicating and using practice recommendations. 
Overview of the consultation  
Thirty-seven researchers and research funders participated in the two-day meeting, which 
combined panel presentations with group discussions that proposed various ways to improve 
evidence to inform RH/FP programming and policy. The objectives for this consultation were: 
1. Suggestions for designing implementation research to maximise the quality of evidence 
generated and its utility for decision-making to strengthen reproductive health practices. 
2. Recommendations for synthesising and grading bodies of evidence on a) reproductive 
health service delivery, and b) other health system building blocks to improve reproductive 
health services. 
3. Proposals to guide appropriate funding and research implementation structures and 
procedures to generate strong evidence for practice recommendations in reproductive 
health. 
The meeting provided a forum to present and discuss a wide range of perspectives. Agreement 
was reached that a consensus was unlikely – and probably unnecessary given the many differing 
evidence needs of decision-makers, the critical role of context in framing the application of 
evidence, the complexity of most FP/RH interventions, and the challenges in ensuring that an 
intervention is implemented at scale in the same way as it was designed and evaluated during 
pilot-testing. Meeting participant discussed the complexity of evidence generation and synthesis 
for identifying evidence-based practices in FP/RH and valued the opportunity to learn from a 
highly experienced group of participants. 
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HIGHLIGHTS 
The meeting began with an overview of the HIP initiative, which identifies and generates a strong 
evidence base for service delivery and enabling environment practices that are most likely to 
support a FP/RH programme in achieving high impact (defined as improved health behaviours 
and/or outcomes). Depending on the strength of evidence available, HIPs are categorised as 
proven, promising, or emerging. Five challenges to determining the standards of evidence for 
guiding FP/RH programming were identified during the first consultation [Shawn Malarcher]: 1) 
research on FP lacks a common language; 2) there are no absolute agreed outcome measures; 
3) strength of evidence varies greatly; 4) contexts are varied and complex; and 5) insufficient 
lessons are learnt from failures. 
Angela Baschieri described DFID’s multifaceted approach to generating and using evidence 
throughout its policy and programming cycle. Strategies include an ‘Evidence into Action’ team, 
commissioning evidence products (e.g. systematic reviews, rapid reviews, literature reviews, 
evidence papers), a policy research fund, several research programme consortia (e.g. STEP UP), 
a maternal health platform, and core funding for WHO’s Human Reproduction Programme. 
DFID’s ‘Framework for Results’ for improving reproductive, maternal, and newborn health in the 
developing world was informed by numerous evidence products to determine which 
implementation strategies represented the best value for money (VfM).  
John Cleland highlighted several differences between research on FP/RH interventions and on 
disease/death prevention interventions: the efficacy, effectiveness, and safety of contraceptive 
products are well established; FP/RH research is primarily focused on optimizing supply and 
demand interventions; intensity of demand varies widely, whereas disease/death prevention is 
universal; evidence is largely derived from observational studies with relatively few experimental 
studies [see Mwaikambo et al. for a review]; and programming is informed more by accumulated 
experience and evidence of implementation than by systematic reviews or randomised controlled 
trials (RCTs). Cleland concluded by identifying common weaknesses in FP/RH evaluation 
designs and recommended that future FP/RH research should seek to use quasi-experimental or 
experimental designs when possible, take advantage of strengthened monitoring and evaluation 
(M&E), include economic evaluations, and be implemented through closer collaboration between 
implementers and researchers. 
Types of design and quality of evidence generated 
Karen Hardee provided an overview of systems used to rate the strength of evidence that informs 
decision-making. Hierarchies for rating evidence have predominated in healthcare decision-
making, drawing primarily from Gray’s rating which ranks evidence from systematic reviews of 
RCTs as strong and evidence from quasi-experimental and non-experimental studies as weak. 
These hierarchies, designed originally for clinical practice, have been developed to rate evidence 
of intervention effectiveness. The challenges of interpreting evidence that is rated as ‘weak’ were 
discussed extensively, especially as related to recommending interventions for FP/RH 
programming. The limitations of this hierarchy in rating evidence to inform research questions 
other than intervention effectiveness (e.g. intervention implementation, salience, acceptability, 
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etc.) were discussed, and an alternative typology was presented [Petticrew & Roberts] that rates 
evidence according to the type of question it is being used to inform. 
James Hargreaves started his presentation from the premise that randomised trials are the most 
efficient and simplest to understand design option for addressing questions about impact and 
effectiveness. However, they are not always feasible and may be inappropriate for other types of 
questions. Alternative designs were discussed (e.g. pragmatic randomisation, process evaluation, 
stepped wedge/phased implementation, randomised ‘encouragement’ to perform an intervention, 
interrupted time series, and systematic non-random allocation with regression discontinuity), with 
examples provided for illustration. 
Many FP/RH interventions are multi-faceted because they need to intervene at multiple levels in a 
causal chain, operating through distal causes and affecting distal outcomes [Campbell]. However, 
evaluation of complex interventions using RCTs is difficult for many reasons and thus is usually 
not an appropriate design. An additional alternative to those described by Hargreaves is to 
strengthen data collection to measure outputs and, if possible, outcomes through an M&E system 
designed for an FP/RH intervention implemented at scale in different settings and populations 
and with variations in the intervention design. Such data can provide an understanding of how the 
intervention functions in ‘real life’; however, the M&E system must be able to measure outcomes 
as well as inputs, process, and outputs. Doing so can be challenging as most M&E systems do 
not collect population-level data. This evaluation approach is dependent on a well-constructed 
and clearly understandable theory of change [Vogel, I.] that explains how the intervention is 
meant to work, its purpose and goal, and the assumptions underlying the causal pathways that 
translate implementation into outputs and outcomes. 
Theories of change are often not specified in sufficient detail prior to implementing an intervention, 
and/or there may be different understandings among implementers, researchers, and funders of 
how an intervention is meant to work and its purpose. A case study of a theory of change for 
evaluating a safe abortion intervention in India was presented by Carine Ronsmans. Intervention 
implementers are trying to maximise the programme’s outputs; evaluators are seeking to 
maximise attribution of the observed outcomes to the programme; and the funder wants both. 
Tensions can emerge as a result of unclear expectations; for example, implementers may want to 
introduce the intervention into locations most likely to serve the largest population so as to 
maximise outputs, while evaluators would prefer to randomise placement of the intervention to 
maximise validity of the findings. A well-constructed theory of change should clarify to 
implementers, funders, and evaluators which questions a research study or evaluation can and 
cannot answer and enable the perspectives of each group to be considered jointly to permit 
consensus on intervention and research designs. 
Ulla Kou Griffiths presented an overview of economic evaluation, defined as the comparative 
analysis of alternative interventions in terms of their costs and consequences, which can inform 
evidence-based decisions on the most effective way of using scarce resources. Key components 
of an economic evaluation are a cost-effectiveness ratio of the incremental cost per outcome 
unit that can be used to compare alternative interventions (including the status quo) and a clearly 
designed ‘decision analytic model’ by which this ratio can be estimated. Economic evaluations 
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can usually be built into impact evaluations, but have rarely been used when assessing FP/RH 
interventions. While the cost-effectiveness of providing FP services to improve maternal health 
has been rigorously documented (see presentation by Darroch), decision-makers frequently lack 
information on how best to use funds within a FP/RH programme, how interventions are most 
efficiently delivered in various settings, and how related services can be cost-effectively 
integrated. 
Jacqueline Darroch presented the economic evaluation (known as ‘Adding it Up’) that is used by 
DFID, USAID, UNFPA, and others to explain the comparative advantage of investing in FP/RH 
services [Singh et al.] and to justify such investments to governments and other donors. The 
evidence from this analysis has also been used effectively in supporting the rationale for the 
FP2020 initiative. The ‘decision analytic model’ for this economic evaluation compares various 
scenarios in terms of the impact of meeting women’s needs for contraception on averting 
undesired events (e.g. unintended pregnancies, maternal deaths/DALYs, neonatal and infant 
deaths) and then estimates the cost per ‘event averted.’ 
Synthesising and summarising bodies of evidence  
Systematic reviews of bodies of evidence are usually considered the highest-ranked methodology 
for synthesising evidence of intervention effectiveness (see Hardee) for narrowly defined 
measures of impact and for relatively simple interventions that can be feasibly evaluated by an 
RCT. As indicated above, RCTs have numerous limitations for evaluating FP/RH interventions, 
given their complexity and need to adapt to specific contexts. Rachel Isba described the benefits 
and shortcomings of using the standard systematic review process (based on the experiences of 
the Cochrane Infectious Diseases Group), and compared this with other review processes 
commonly used by DFID, USAID, and others, such as ‘expert reviews’ and ‘structured literature 
reviews’. While recognising that systematic reviews synthesise evidence drawn primarily from 
RCTs, Isba outlined conditions under which evidence from quasi-experimental and non-
randomised designs could be incorporated into standard systematic reviews, by ensuring that the 
risks of bias and confounders are carefully assessed when summarising the findings. The utility of 
formal systematic reviews for synthesising evidence of the impact and implementation of FP/RH 
interventions stimulated extensive discussion and revealed differences of opinion. The 
recommendations presented later represent a meeting consensus, but one that was not 
unanimous. 
Communicating evidence-informed recommendations to decision-makers needs to be undertaken 
carefully, especially when ‘low’-quality evidence supports a ‘strong’ recommendation or ‘high’-
quality evidence supports a ‘weak’ recommendation. Indeed, the terminology used to describe the 
relative ‘strength’ of evidence and of the recommendations that can be made stimulated intense 
discussion. Will Evans discussed modalities for summarizing and presenting a body of evidence, 
including detailed narratives proposed by DFID for describing the strength of the evidence, and 
diagrams that can present evidence strength visually. For DFID, the strength of evidence should 
be described and judged in terms of five domains: the size of the body of evidence; its quality; the 
context to which the evidence applies; the consistency of the evidence; and the diversity of 
research methods on which the evidence is based. 
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There are many ways in which a body of evidence can be translated into programmatic 
recommendations. Joshua Vogel described the ‘Grading of Recommendations Assessment, 
Development and Evaluation’ (GRADE) approach used by WHO, which has two sequential 
phases: i) assessing the quality of the evidence (high, moderate, low, very low) in terms of the 
extent to which a decision-maker can be confident that an estimate of effect or association is 
correct as determined by the methodological quality of evidence and the likelihood of bias (all 
evidence from non-RCTs is considered low quality); and ii) the strength of the recommendation 
that can be made for or against using the intervention based on this evidence, usually 
categorised as strong or weak/ conditional/ qualified. WHO is also using the ‘Developing and 
Evaluating Communication Strategies to Support Informed Decisions and Practice Based on 
Evidence’ (DECIDE) framework [Vogel, J. et al.] to improve the dissemination of 
recommendations developed through GRADE. The framework includes 10 criteria (seriousness 
of the problem, number of people affected, quality of the evidence, size of the benefits, size of the 
adverse effects, resource use (costs), value for money, impacts on equity, feasibility, and 
acceptability) that help determine which health system decisions can be made, by using evidence 
to inform judgements about each criterion.  
Mary Lyn Gaffield provided further insights into the procedures followed by WHO in developing 
practice guidelines, which are defined as any document that contains WHO recommendations 
about health interventions. A recommendation “provides information about what policy-makers, 
health-care providers or patients should do. It implies a choice between different interventions 
that have an impact on health and that have ramifications for the use of resources.” Various types 
of guidelines have been developed, all of which have to follow a standard process of 
development [WHO 2012] that is managed by a Guideline Development Group, reviewed by an 
External Review Group, formulates PICO (population, intervention, comparator, outcome) 
questions to be addressed, uses GRADE, and can take 3–37 months. 
David Ross described another method for synthesising evidence and developing 
recommendations that adapted the principles of systematic review to summarise evidence to 
inform specific questions posed by policymakers. This method synthesises evidence from 
evaluations of specific interventions designed for particular populations and delivered in defined 
contexts. It assumes that different intervention types will need different strengths of evidence in 
order to recommend scaling up, and so assesses the evidence in terms of whether it reaches a 
particular threshold from which a recommendation can be made. The evidence is reviewed in 
relation to a hierarchy of contexts, firstly determining whether there is sufficient evidence of the 
intervention’s effect within a specific population group and context, and then assessing evidence 
from the intervention in similar populations in other contexts. The strength of evidence available 
for each type of intervention / context is then assessed using a hierarchy similar to that outlined 
by Hardee, and a decision is made as to whether the threshold of evidence needed for a 
recommendation on implementation and scale-up has been reached based on six domains 
(feasibility, cost, potential for adverse outcomes, acceptability, potential size of the effect, and 
other health or social benefits). Depending on the threshold of evidence reached, the 
recommendation is framed as ‘Steady’ (more evidence needed), ‘Ready’ (proceed with careful 
M&E), ‘Go’ (proceed with widespread implementation), or ‘Do not go.’ 
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The fields of implementation science (IS) and health policy and systems research (HPSR) offer 
several methodologies that can generate evidence to enable decision-makers to understand why 
and how interventions work. Nhan Tran provided an overview of implementation research which 
draws on both fields. Health systems are unique and continually changing. Consequently, 
intervention implementation is necessarily adaptive, iterative, and dynamic; and decisions need to 
be evidence-informed rather than evidence-based, drawing from a range of options and 
accounting for factors other than solely research-based evidence. Implementation research is the 
scientific study of the processes used in the implementation of interventions as well as the 
contextual factors that affect these processes. The evidence generated and summarised is used 
to support and promote the effective application and scale-up of interventions that have been 
demonstrated to be effective in a range of contexts. The research design and methods used for 
implementation research, and thus the quality of evidence generated, depend entirely on the 
nature of the implementation question being addressed; Peters et al. provide a review of 
approaches used for implementation research. Standards for reporting and publishing 
implementation research results have been developed, e.g. SQUIRE [Davidoff et al.], which can 
also be used to assess the quality of evidence generated; these focus on clarity of description 
and appropriateness of the research for the implementation question being addressed. 
Because systematic reviews of RCTs are not necessarily appropriate for informing decisions on 
how an FP/RH intervention should best be designed and implemented, alternative approaches 
were discussed for synthesising the evidence from implementation research. Marjolein Dieleman 
presented the realist synthesis approach, which seeks to understand and summarise what 
characteristics of an intervention enable it to work (or not), for whom, and in what circumstances. 
A realist synthesis starts by specifying the theory of change that explains how an intervention is 
expected to work and assumes that FP/RH interventions may be implemented differently 
depending on the context and the implementers. A systematic review process is then followed to 
identify and extract evidence from published studies on the intervention. This body of evidence is 
analysed by searching for patterns in the way the mechanism functions and the outcomes it 
produces in different contexts. The search is guided by the theory of change and results in a 
description that incorporates both the outcomes associated with the intervention and how it 
functions in various contexts. 
A common feature of the various approaches to summarising a body of evidence is the 
expectation that decisions should be based on an evidence framework, which uses multiple 
domains to arrive at a summary judgement of the evidence. Ian Askew summarised the key 
characteristics of a typical evidence framework as being systematic and rigorous, having 
transparent procedures to reach a summary judgement, and rating evidence across multiple 
domains. A study by Luoto et al., which summarised the same body of evidence using six 
different evidence frameworks (including those of the U.S. Community Preventive Services Task 
Force, UK National Health Service Health Development Agency, WHO (GRADE), and the 
Australian National Health and Medical Research Council), found that the choice of framework 
influences the type of recommendations that can be made. While variability in how the 
frameworks are applied may influence the evidence summary and recommendations, the choice 
of domains included in the framework and how they are rated and weighted are critically 
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important, especially for domains relating to implementation, context, and cost. Choice of 
domains to include in an evidence framework should be influenced by whether the decision 
requires evidence of efficacy (e.g. choice of service delivery intervention), of feasibility and 
implementation (e.g. population level impact of a service delivery model), or of sustainability at 
scale (e.g. context and cost). 
SUMMARY AND RECOMMENDATIONS 
Drawing from these presentations, three plenary discussions were held during which participants 
sought clarification and critiqued the issues presented. Discussions reflected a diversity of views 
on what constitutes high-quality evidence, which type of evidence is appropriate for which type of 
recommendations, and which approaches should be followed to translate evidence into practice 
recommendations. During each discussion, recommendations were made for consolidating 
standards of evidence and formulating guideline recommendations for high-impact practices in 
FP/RH programming and policy making as follows: 
 Suggestions for designing implementation research to maximise the quality of evidence 
generated and its utility for decision-making to strengthen reproductive health practices; 
 Recommendations for rigorously synthesising and grading bodies of evidence; 
 Proposals to guide appropriate funding and research implementation structures and 
procedures to generate strong evidence for practice recommendations in FP/RH. 
The recommendations from these discussions are presented below. 
Designing implementation research to maximi se the quality of 
evidence generated and its utility for decision -making 
1. Much of the confusion concerning quality of evidence stems from applying an inappropriate 
standard of evidence to a particular research question. Most of the evidence generated and 
communicated for guiding FP/RH programming recommendations has sought to answer 
questions such as “what works?”, “does this work better than that?”, or “is it safe?”, i.e. 
questions of impact, effectiveness, and safety. While questions about intervention 
effectiveness are still being asked and require a standard of evidence with high internal 
validity, policymakers, programme managers, and funders are increasingly seeking to better 
understand how and why an intervention works; to strengthen implementation procedures and 
service quality; to determine whether an intervention is acceptable, appropriate, and affordable 
for different populations; and to forecast the resources required to sustain and scale-up 
effective interventions [Hardee; Cleland]. 
 Different decisions require different types of evidence generated through 
different study designs; consequently the utility of research-based evidence will 
depend on its capacity to inform a particular decision. 
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2. The highest quality of evidence for evaluating the impact and effectiveness of an 
intervention is generated by designs that produce strong internal validity, i.e. which can 
demonstrate that an intervention is the only or main cause of the outcomes observed 
[Hardee; Hargreaves]. Internal validity is strongest when the research compares the impact 
of an intervention on individuals or on ‘clusters’ (groups of individuals or units such as health 
facilities) that have been randomly assigned to receive or not receive the intervention, or to 
receive different interventions. 
 When evaluating impact and effectiveness, and when randomisation does not 
compromise the utility of the findings and is affordable, randomisation should be 
used to reduce the possibility that factors other than the intervention influence 
the outcomes. 
3. However, randomisation is generally not feasible if an intervention is complex, if the 
implementation site has been pre-determined, or if it would be unethical in certain contexts. 
Moreover, implementation may require a specific context that cannot be replicated or scaled-
up [Campbell]. Furthermore, intervention sites are often intentionally selected by funders, 
implementers, and other decision-makers, and so it may not be feasible to randomise study 
sites. A range of quasi-experimental / non-randomised designs use different means of 
comparison to reduce the threats to internal validity and so can produce high-quality evidence 
of intervention effectiveness and impact. Such designs include systematically matching 
intervention and comparison populations through use of intervention and control groups, 
and/or using statistical adjustments to create an equivalent comparison [Hargreaves]. 
 Evaluations of intervention effectiveness that cannot randomise the unit of 
analysis can instead use systematic comparisons of intervention and control 
groups through matching or statistical adjustment to generate high-quality 
evidence of impact. Evaluations that use neither randomisation nor systematic 
comparison generate lower-quality evidence that should be interpreted with 
caution. 
4. Designs to evaluate the impact of interventions, especially complex interventions with 
multiple outcomes, or to understand implementation procedures, should be guided by an 
explicit theory of change (ToC) [Cleland; Campbell]. A ToC should clearly describe an 
intervention, how it is expected to influence a change, and the type and level of change that it 
can realistically achieve. Impact should also be measured in terms of equity in access to and 
use of services among the beneficiaries. A strong ToC also describes the implementation 
processes needed for the intervention to achieve the desired outcomes. Without a clear ToC 
and a study design to evaluate it, attribution of impact to a particular intervention cannot be 
proven. 
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 Agreement on the theory of change and alignment of the evaluation design with 
the ToC should be reached between the implementing partner, evaluator, and 
funder before research is initiated. 
5. An economic evaluation measures the costs and cost-effectiveness ratio of 
implementation, that is, the incremental cost of achieving the impact by implementing the 
intervention compared with the existing service delivery approach and/or with other 
comparable interventions; this is usually measured as a cost per outcome unit (e.g. per 
unintended pregnancy averted) [Griffiths]. These costs and ratios can then be modelled to 
inform decisions on improving implementation efficiencies, forecasting resource needs for 
scale-up, and allocating resources between alternative interventions to avert the adverse 
events of unintended pregnancy [Darroch]. Incorporating evidence of costs into decision-
making must be carefully balanced with ensuring that a cost-effective intervention also 
reduces inequities. 
 Whenever affordable, feasible, and appropriate, an impact evaluation should 
include an economic evaluation component so that the feasibility of scale-up and 
sustainability of a proven high-impact practice can be determined. 
6. When decision-makers need guidance on how a high-impact intervention can be 
implemented at scale, evidence can be generated through documenting both the process of 
implementation and the contextual factors influencing procedures for intervention 
implementation [Campbell; Tran]. Implementation research can provide evidence to inform 
guidance for institutionalizing and strengthening an intervention within a health system, for 
guiding and assessing quality improvements, and for supporting an intervention’s scale-up 
and replication in other systems and contexts. 
 Implementation research using mixed-methods design should be used to 
generate high-quality evidence describing intervention procedures and context 
to inform decisions about scale-up and sustainability; the specific study design 
should be determined by the information needed by decision-makers. 
Recommendations for synthesising and grading  bodies of 
evidence on reproductive health  
1. Recommendations for guiding decisions on practice effectiveness are based on bodies of 
evidence that have been summarised and synthesised and whose findings have been rated 
by an expert panel. These processes of summarising and synthesising evidence on practice 
effectiveness draw from evidence with high internal validity, including from both randomised 
and rigorously implemented comparative non-randomised designs. Non-randomised designs 
should specify explicit inclusion and exclusion criteria, specify potential biases and 
confounders, and describe the probability of an intervention causing a desired impact [Isba; 
Ross]. 
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 Bodies of evidence that inform decision-makers on the effectiveness of 
interventions are best summarised using a transparent, structured review 
process that includes evidence from both randomised and rigorous non-
randomised designs with systematic comparisons. 
2. Deciding whether to introduce or scale-up an intervention needs to be informed by evidence 
other than solely its effectiveness or cost-effectiveness, however. Practice recommendations 
for guiding the introduction and scaling up of interventions demonstrated to have high 
impact should also be informed by bodies of evidence derived from implementation 
research [Tran] that include feasibility, generalizability, and scalability [Ross]. While such 
bodies may include evidence from randomised and/or comparative designs, research 
methods that describe implementation procedures, and explain them within the context in 
which they are operating, usually provide higher-quality evidence for informing such ‘how to’ 
decisions. A rigorous review process should also be followed to summarise evidence from 
implementation research. A realist synthesis [Dieleman] that specifies a ToC and assumes 
that FP/RH interventions may be implemented differently depending on the context and the 
implementers can provide a structured framework for such reviews.  
 Bodies of evidence to inform implementation and scaling-up decisions can be 
derived from implementation research and economic evaluations. Highest-quality 
data are generated when the decision question is clearly stated and the research 
design tailored to generate evidence that will address that question.  
 Such bodies of evidence should be guided by a theory of change, reviewed 
rigorously, synthesised systematically, and summarised to inform 
implementation decisions identified by decision-makers. 
3. Summarising the key findings from a body of evidence into recommendations that can be 
translated into practice guidelines requires an evidence framework that rates evidence 
across multiple domains to arrive at a summary judgement [Askew]. Examples of such 
frameworks include GRADE [Vogel], “Steady, Ready, Go!” [Ross], and DFID’s assessment 
framework [Evans]. The domains used within an evidence framework will influence the 
conclusions that can be drawn and the recommendations than can be made; thus careful 
attention must be paid to the configuration and clear explanation of the evidence framework 
used. 
 A systematic, transparent, and replicable process, guided by an explicit evidence 
framework, should be followed when developing practice recommendations from 
a body of evidence. The evidence framework should incorporate those domains 
that are of specific interest to particular decision-makers; different evidence 
frameworks may be appropriate for summarising evidence to inform different 
types of decisions. 
11 
4. Great care is needed when interpreting an evidence summary and communicating the 
findings through narrative statements or diagrammatically to ensure that the various domains 
are clearly described and the rating accurately reflects the available evidence [Evans]. 
Formulating recommendations is usually undertaken by an expert group or panel that is 
convened for the purpose [Malarcher; Gaffield], and that follows systematic, rigorous, and 
fully transparent procedures. Communicating recommendations for ‘what’ to do will 
necessarily be framed differently than recommendations for ‘how’ to do it. 
 Recommendation formulation should be carefully planned and implemented, 
using a representative and knowledgeable expert group and recommendation 
statements or diagrams that accurately and unequivocally represent the body of 
evidence available. 
 Given the diversity of contexts in which RH/FP interventions are implemented, 
recommendations for implementation should offer a choice of options – that is, 
should be ‘evidence-informed’ – rather than specify a single ‘evidence-based’ 
recommendation for addressing a particular need or problem. 
Funding and research implementation structures and procedures 
to generate quality evidence and strong recommendations  
Panel discussions with representatives from donors (DFID; USAID; Bill and Melinda Gates 
Foundation; Packard Foundation; Alliance for Reproductive, Maternal and Newborn Health) and 
from research organisations (London School of Hygiene and Tropical Medicine; Population 
Council; FHI360; Columbia University; University of North Carolina; University of Ghana; Harvard 
University), followed by discussions in plenary, led to the following suggestions: 
 External evaluations that separate the roles of donor, implementer, and researcher have 
been the norm for most donor-funded impact evaluations. Experience suggests that funding 
and designing research on FP/RH interventions so that donors, researchers, and 
implementers can work jointly and with complementary roles produces evidence that 
is relevant and useful for decision-makers, without compromising the quality of 
evidence. 
 Challenges encountered when implementing and evaluating interventions, especially 
complex interventions, must be documented so that lessons learned from ‘failure’ can 
be shared and inform the reconfiguration of an intervention’s structure and 
procedures prior to scaling up. 
 A decision regarding which research design is most appropriate for generating 
evidence to address decision-makers’ specific needs should be made jointly by 
donors, researchers, and implementers through a consultative process prior to 
initiating research. These consultations should be informed by an awareness of the variety 
of designs that can be used, and the type and quality of evidence they can generate. 
12 
 The evidence frameworks for rating evidence used by organisations that set service delivery 
and programming norms, and those that fund research and guideline development, vary 
considerably. Reducing the variability among and consolidating the key domains and 
rating scales used in different evidence frameworks, together with more transparent 
evidence review processes, would reduce the likelihood of differing interpretations of 
a body of evidence, thereby reinforcing the strength of recommendations. 
 As country strategy plans are being reviewed, revised, and costed through initiatives such as 
Every Woman, Every Child and FP2020, and investments in large-scale expansion of FP/RH 
programme coverage are being made, there are multiple needs and opportunities for high-
quality evidence on implementation. Donors and researchers should prioritise investment 
in and application of implementation research to improve the quality of evidence to 
guide rapid scale-up of HIPs and other recommended FP/RH practices. 
 Despite decades of investment in building research capacity, a lack of individual and 
institutional capacity still exists for undertaking impact evaluations and implementation 
research on FP/RH interventions in most developing countries. Donors, governments, and 
research organisations should increase investments in a wide range of skills-building 
and systems-strengthening activities to enhance and sustain national research 
capacities. Priorities should include strengthening HMIS and M&E capacities of service 
delivery programmes, building researcher skills in design and analysis methodologies for 
generating internally valid data, and intensifying ethical and technical review processes for 
national research regulatory bodies. 
 Communicating and packaging practice recommendations and guidelines so that they convey 
appropriate and valid messages and provide decision-makers with sufficient evidence to 
make a particular decision has been challenging. Recommendations on FP/RH 
interventions should include guidance on the contexts and populations for which they 
may (or may not) be effective and reduce inequities, and on how best to implement 
them in such contexts. Recommendations should offer a range of options from which 
to choose, so that programming decisions are evidence-informed. 
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